Interventional Cardiology Sirolimus-Eluting Stent Versus Balloon Angioplasty for Sirolimus-Eluting Stent Restenosis: Insights From the j-Cypher Registry

نویسندگان

  • Mitsuru Abe
  • Takeshi Kimura
  • Takeshi Morimoto
  • Takuya Taniguchi
  • Futoshi Yamanaka
  • Yoichiro Kasahara
  • Atsushi Kawamura
  • Shunichi Miyazaki
  • Koichi Nakao
  • Koichi Kishi
چکیده

Mitsuru Abe, MD; Takeshi Kimura, MD; Takeshi Morimoto, MD, MPH; Takuya Taniguchi, MD; Futoshi Yamanaka, MD; Kazuhiro Nakao, MD; Nobuhito Yagi, MD; Nobuaki Kokubu, MD; Yoichiro Kasahara, MD; Yu Kataoka, MD; Yoritaka Otsuka, MD; Atsushi Kawamura, MD; Shunichi Miyazaki, MD; Koichi Nakao, MD; Kenji Horiuchi, MD; Akira Ito, MD; Hiroshi Hoshizaki, MD; Ren Kawaguchi, MD; Manabu Setoguchi, MD; Tsukasa Inada, MD; Koichi Kishi, MD; Hiroki Sakamoto, MD; Nobuyuki Morioka, MD; Masao Imai, MD; Hiroki Shiomi, MD; Hiroshi Nonogi, MD; Kazuaki Mitsudo, MD; for the j-Cypher Registry Investigators

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Sirolimus-eluting stent versus balloon angioplasty for sirolimus-eluting stent restenosis: Insights from the j-Cypher Registry.

BACKGROUND Optimal treatment strategies for restenosis of sirolimus-eluting stents (SES) have not been adequately addressed yet. METHODS AND RESULTS During the 3-year follow-up of 12 824 patients enrolled in the j-Cypher registry, 1456 lesions in 1298 patients underwent target-lesion revascularization (TLR). Excluding 362 lesions undergoing TLR for stent thrombosis or TLR using treatment moda...

متن کامل

INTERVENTIONAL CARDIOLOGY AND SURGERY Routine sirolimus eluting stent implantation for unselected in- stent restenosis: insights from the rapamycin eluting stent evaluated at Rotterdam cardiology hospital (RESEARCH) registry

F Saia, P A Lemos, C A Arampatzis, A Hoye, M Degertekin, K Tanabe, G Sianos, P C Smits, W J van der Giessen, P J de Feyter, R T van Domburg, P W Serruys . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ...

متن کامل

Efficacy of various percutaneous interventions for in-stent restenosis: comprehensive network meta-analysis of randomized controlled trials.

BACKGROUND In-stent restenosis (ISR) remains a difficult problem in interventional cardiology. The relative efficacy and safety of available interventions is not clear. We aimed to perform a network meta-analysis using both direct evidence and indirect evidence to compare all available interventions. METHODS AND RESULTS We systematically searched electronic databases for randomized trials com...

متن کامل

نتایج بالینی پس از آنژیوپلاستی عروق کرونر، بروز حوادث بزرگ قلبی-عروقی و عوارض انواع استنت

Background: Cardiovascular diseases alone have become the leading cause of death worldwide. One of the treatment methods cardiovascular disease is angioplasty. This study aimed to investigate the clinical results after coronary artery angioplasty, based on the incidence of major cardiovascular events with emphasis on stent types. Methods: In this retrospective cross-sectional study, the preval...

متن کامل

Update on the everolimus-eluting coronary stent system: results and implications from the SPIRIT clinical trial program

Drug-eluting stents (DES) have had a major impact in interventional cardiology. Compared to bare metal stents, they significantly reduce restenosis and the need for target vessel revascularization. Four DES are available in the US, the first-generation sirolimus-eluting (Cypher((R))) and paclitaxel-eluting (Taxus((R))) stents and later approved second-generation everolimus-eluting (Xience V((R)...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2010